Group One Trading’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-766,908
| Closed | -$5.25M | – | 8106 |
|
|
2025
Q4 | $1.52M | Sell |
766,908
-391,857
| -34% | -$888K | ﹤0.01% | 2512 |
|
|
2025
Q3 | $2.85M | Buy |
1,158,765
+383,464
| +49% | +$988K | 0.01% | 1969 |
|
|
2025
Q2 | $2.05M | Sell |
775,301
-570,735
| -42% | -$1.53M | ﹤0.01% | 2118 |
|
|
2025
Q1 | $4.05M | Buy |
1,346,036
+847,607
| +170% | +$2.57M | 0.01% | 1236 |
|
|
2024
Q4 | $1.28M | Buy |
+498,429
| New | +$2.08M | ﹤0.01% | 2327 |
|
|
2023
Q4 | – | Sell |
-446,743
| Closed | -$1.4M | – | 7734 |
|
|
2023
Q3 | $755K | Buy |
+446,743
| New | +$897K | ﹤0.01% | 2539 |
|
|
2023
Q2 | – | Sell |
-153,089
| Closed | -$433K | – | 7903 |
|
|
2023
Q1 | $279K | Sell |
153,089
-168,004
| -52% | -$522K | ﹤0.01% | 3356 |
|
|
2022
Q4 | $1.63M | Sell |
321,093
-59,595
| -16% | -$327K | ﹤0.01% | 2011 |
|
|
2022
Q3 | $1.89M | Buy |
380,688
+31,436
| +9% | +$143K | ﹤0.01% | 1972 |
|
|
2022
Q2 | $1.3M | Sell |
349,252
-43,752
| -11% | -$176K | ﹤0.01% | 2483 |
|
|
2022
Q1 | $2.21M | Buy |
393,004
+152,215
| +63% | +$934K | ﹤0.01% | 2306 |
|
|
2021
Q4 | $1.46M | Buy |
+240,789
| New | +$1.81M | ﹤0.01% | 2941 |
|
|
2021
Q2 | – | Sell |
-10,544
| Closed | -$174K | – | 8321 |
|
|
2021
Q1 | $250K | Sell |
10,544
-92,327
| -90% | -$2.39M | ﹤0.01% | 4784 |
|
|
2020
Q4 | $1.37M | Buy |
102,871
+25,010
| +32% | +$241K | ﹤0.01% | 2356 |
|
|
2020
Q3 | $540K | Buy |
+77,861
| New | +$776K | ﹤0.01% | 2774 |
|
|
2020
Q2 | – | Sell |
-10,892
| Closed | -$61.5K | – | 5948 |
|
|
2020
Q1 | $31K | Sell |
10,892
-442
| -4% | -$2.21K | ﹤0.01% | 4005 |
|
|
2019
Q4 | $43K | Sell |
11,334
-7,555
| -40% | -$12.9K | ﹤0.01% | 4076 |
|
|
2019
Q3 | $23K | Buy |
+18,889
| New | +$23.4K | ﹤0.01% | 4311 |
|
|
2019
Q2 | – | Sell |
-32,900
| Closed | -$38K | – | 5136 |
|
|
2019
Q1 | $52K | Buy |
32,900
+32,400
| +6,480% | +$40.7K | ﹤0.01% | 3547 |
|
|
2018
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 4729 |
|
|
2018
Q3 | $2K | Buy |
+500
| New | +$1.58K | ﹤0.01% | 5014 |
|
|
2018
Q1 | – | Sell |
-1,133
| Closed | -$4.97K | – | 5040 |
|
|
2017
Q4 | $5K | Buy |
+1,133
| New | +$5.37K | ﹤0.01% | 4558 |
|
|
2016
Q3 | – | Sell |
-607
| Closed | -$4.54K | – | 4694 |
|
|
2016
Q2 | $4K | Hold |
607
| – | – | ﹤0.01% | 4321 |
|
|
2016
Q1 | $5K | Sell |
607
-2,500
| -80% | -$23.6K | ﹤0.01% | 4197 |
|
|
2015
Q4 | $54K | Buy |
+3,107
| New | +$46.1K | ﹤0.01% | 3356 |
|
Other funds holding IBRX
Group One Trading's IBRX Position: Q1 2026 in Review
Group One Trading sold out of ImmunityBio (IBRX) in Q1 2026, closing a stake of 766,908 shares — an estimated $5.25M sold.
Group One Trading first reported a position in IBRX in Q4 2015 and held it in 25 quarters. The position peaked at $4.05M in Q1 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.
- Group One Trading reported no remaining ImmunityBio position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 766,908 ImmunityBio shares in Q1 2026, an estimated $5.25M.
- Group One Trading first reported a position in ImmunityBio in Q4 2015 and held it in 25 quarters.
- Group One Trading's ImmunityBio position peaked at $4.05M in Q1 2025.
- 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.